SCHEDULE: AIGH Capital Management Discloses 7.7% Stake in Biodesix

AIGH Capital Management LLC and affiliated entities report beneficial ownership of 7.7% of Biodesix, Inc. common stock as of March 31, 2026.

Summary

• AIGH Capital Management LLC, along with AIGH Investment Partners, L.L.C. and Orin Hirschman, have jointly filed a Schedule 13G.
• The filing indicates beneficial ownership of 758,328 shares of Biodesix, Inc. common stock.
• This ownership represents approximately 7.7% of the class of securities.
• The reporting persons have sole voting power and sole dispositive power over these shares.
• The date of the event requiring this filing is March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of ownership and does not inherently signal positive or negative performance for Biodesix.

Positives

• Significant ownership stake (7.7%) by AIGH Capital Management and affiliates, potentially indicating confidence in Biodesix's future.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of current ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant stakeholders, indicating a notable position in Biodesix's shareholder base. This level of ownership by AIGH Capital Management suggests active investment interest in the company.

Stakeholder Impact

• Shareholders: The filing informs shareholders about a significant institutional investor's stake, which could influence market perception and trading activity.

Key Dates

Keywords

Biodesix, Schedule 13G, AIGH Capital Management, Orin Hirschman, Beneficial Ownership, Common Stock, SEC Filing, Investment